Cigna, Humana Merger Deal 'Math Now Works,' Jefferies Says.

Cigna Group may resume its pursuit of Humana Inc. after the stock prices of both companies have shifted, making a potential merger financially viable. Talks between the two companies fell through in November due to disagreements over price, but with Humana's stock down 32% and Cigna's up 36%, an acquisition is now seen as possible. Analysts suggest a deal for around $420 per Humana share could be feasible. However, Cigna should not pay more than $470 per share, and Humana needs to reach earnings of $23 per share in 2027 for the acquisition to contribute to Cigna's growth. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)